vendredi 3 février 2017

Onco Actu du 3 février 2017


1. Biologie

NIH to expand critical catalog for genomics research [NIH]


4. Dépistage, diagnostic et pronostic

Navigating Changing Guidelines on Cancer Screening [Cancer Research Catalyst]

4.10 Dép., diag. & prono. - Poumon

Lung Cancer Screening Rates Remain Very Low among Current and Former Smokers [ACS]

5. Traitements

New Therapy Benefits Patients with Neuroendocrine Tumors [NCI]

5.12.3 Immunothérapies-combinaisons

AstraZeneca pulls PD-L1 phase 3 combo test, RSV candidate [FierceBiotech]

5.12.5 Immunothérapies - Pharma

AstraZeneca chief is betting the company’s future on a single roll of the dice [EndPoints]

5.2 Pharma

AstraZeneca CEO: We want a ‘strong, science-led FDA’ [FierceBiotech]

Side Effect Kills Cancer Patient in Stemline Therapeutics Drug Trial; Company Raises Money [The Street]

5.3.4 Traitements - AMM (FDA, EMA)

Nivolumab for Treatment of Urothelial Carcinoma [FDA]

Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma, a Type of Bladder Cancer [BMS]

5.4 Traitements - Economie

The ICR responds to decision by NICE not to recommend palbociclib [The Institute of Cancer Research]

Immunotherapy treatment fast-tracked under UK’s access to medicines scheme [European Pharmaceutical Review]

Breast cancer drug costs too high in relation to benefits for routine NHS funding [NICE]

Most important breast cancer drug in two decades will not get NHS funding [The Telegraph]

UK agency says Pfizer breast cancer drug too expensive [Reuters]

6. Lutte contre les cancers

Global cancer survivorship: the need for integrated care [The Economist]

Cancer Survivors Need More Efficient Integrated Long-Term Care and Stronger Policies Across Healthcare, Advocacy and the Workplace, New Research Concludes [BMS]

Study: Children, Parents Over-Report Leukemia Treatment Adherence [ASH]

Last Month in GU Oncology with Dr. Bishal Gyawali: January 2016 [ecancernews]

6.1 Observation

Cancer rates set to increase six times faster in women than men [The Guardian]

6.10.1 Politiques (USA)

Dear President Trump: Don’t destroy the FDA we know and respect [EndPoints]